Strategic Partnerships Global patient advocacy leadership and a wide network of researchers through IMWG presents ongoing opportunities to co-create education, awareness campaigns, and trial recruitment partnerships with pharmaceutical and biotech firms seeking access to diverse patient populations and clinical trial sites.

Clinical Trials Access Recent collaboration with SparkCures to enhance patient participation in clinical trials signals IMF openness to technology-enabled patient matching and trial navigation services, creating potential sales opportunities around enrollment tech, data integration, and patient engagement platforms.

Digital Engagement IMF operates Myelo, a generative-AI assistant, plus a 24/7 InfoLine and digital education programs, indicating strong potential for monetizable digital health tools, tele-support solutions, AI-driven patient education modules, and analytics services.

Funding and Scale With revenue in the mid tens of millions and a lean employee base, IMF represents a cost-effective partner for scalable programs, sponsorships, grants management, and ROI-focused collaborations with vendors offering cloud, CRM, marketing tech, and content automation.

Leadership Transition Recent leadership updates including a new CEO and senior medical advisor role suggest openness to advisory services, executive coaching, strategic consulting, and high-visibility sponsorships aligned with mission-driven growth and fundraising campaigns.